ENDURANT CAPITAL MANAGEMENT LP Relmada Therapeutics, Inc. Transaction History

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

$524,000
portfolio value

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 14.14K shares 524K $37.02 14.14K